Plain-English translation of NCT06979453 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing a medication called to see if it can help teenagers with moderate to severe plaque psoriasis — a skin condition that causes thick, red, scaly patches. Researchers want to find out whether the medication works better than placebo (a dummy pill with no active ingredient), how safe it is, and how the body processes it. About 366 teenagers will participate across multiple hospitals and clinics.
Currently, there are limited treatment options specifically studied and approved for teenagers with severe psoriasis. This trial aims to fill that gap by testing whether this medication is effective and safe enough to offer young people better ways to manage their skin condition.
You likely qualify if…
You likely don't qualify if…
If you join, you will be randomly assigned to either receive the medication or a placebo pill — neither you nor the research team will know which one you're getting at first. You will take your assigned treatment at home and attend multiple clinic visits where doctors will examine your skin, measure how much it has improved, check your blood work, and ask about any side effects. The study will track how the medication works in your body and how safe it is over time.
AI-generated summary from trial data · Aug 15, 2026 · Not medical advice
United States